New Jersey Contract Tester Warned for API Testing Violations By Sam | May 20, 2020 The FDA hit a Paterson, New Jersey contract testing laboratory with a warning letter for active pharmaceutical ingredient (API) testing violations. Source: Drug Industry Daily Posted in Drug Industry Daily